Clinical and molecular characterization of a family affected with X-linked ocular albinism (OA1)

Byron L Lam, J. Fingert, B. C. Shutt, E. M. Singleton, L. M. Merin, V. C. Sheffield, E. M. Stone

Research output: Contribution to journalArticle

Abstract

Purpose. To characterize the clinical phenotype and identify the disease-causing mutation in a family with X-linked ocular albinism (OA1). Methods. 32 members of a family affected with OA1 were examined, and linkage analysis was performed with markers from the OA1 locus. Exons 2 and 8 of the OA1 gene were assayed with the polymerase chain reaction (PCR). Results. The 6 affected males had visual acuities ranging from 20/40 to 20/200. All had nystagmus, iris transillumination, and foveal hypoplasia. The eldest affected male was asymptomatic with 20/40 vision. All 7 female carriers had normal visual function but were found to have iris transillumination defects and variable mosaic pigmentary patterns of the retinal pigment epithelium (RPE). Linkage analysis was consistent with a disease-causing mutation at the OA1 locus. PCR analysis revealed a deletion which includes at least the portion of the OA1 gene between exons 2 and 8. Conclusions. Males affected with OA1 can have a visual disability that ranges from almost none to legal blindness. In this family, the visual acuity seemed related more to the degree of nystagmus than to the degree of RPE pigmentation. Mutation screening of the OA1 gene can be used to confirm the diagnosis in isolated males of some families and genetic linkage analysis can be used to accurately identify carriers even when the specific mutation can't be identified.

Original languageEnglish
JournalInvestigative Ophthalmology and Visual Science
Volume37
Issue number3
StatePublished - Feb 15 1996

Fingerprint

Ocular Albinism
Transillumination
Mutation
Retinal Pigment Epithelium
Iris
Visual Acuity
Exons
Genes
Polymerase Chain Reaction
Genetic Linkage
Pigmentation
Blindness
Phenotype

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Lam, B. L., Fingert, J., Shutt, B. C., Singleton, E. M., Merin, L. M., Sheffield, V. C., & Stone, E. M. (1996). Clinical and molecular characterization of a family affected with X-linked ocular albinism (OA1). Investigative Ophthalmology and Visual Science, 37(3).

Clinical and molecular characterization of a family affected with X-linked ocular albinism (OA1). / Lam, Byron L; Fingert, J.; Shutt, B. C.; Singleton, E. M.; Merin, L. M.; Sheffield, V. C.; Stone, E. M.

In: Investigative Ophthalmology and Visual Science, Vol. 37, No. 3, 15.02.1996.

Research output: Contribution to journalArticle

Lam, BL, Fingert, J, Shutt, BC, Singleton, EM, Merin, LM, Sheffield, VC & Stone, EM 1996, 'Clinical and molecular characterization of a family affected with X-linked ocular albinism (OA1)', Investigative Ophthalmology and Visual Science, vol. 37, no. 3.
Lam, Byron L ; Fingert, J. ; Shutt, B. C. ; Singleton, E. M. ; Merin, L. M. ; Sheffield, V. C. ; Stone, E. M. / Clinical and molecular characterization of a family affected with X-linked ocular albinism (OA1). In: Investigative Ophthalmology and Visual Science. 1996 ; Vol. 37, No. 3.
@article{8ddd3bde9b1b4c6f855ac9bd57f1e645,
title = "Clinical and molecular characterization of a family affected with X-linked ocular albinism (OA1)",
abstract = "Purpose. To characterize the clinical phenotype and identify the disease-causing mutation in a family with X-linked ocular albinism (OA1). Methods. 32 members of a family affected with OA1 were examined, and linkage analysis was performed with markers from the OA1 locus. Exons 2 and 8 of the OA1 gene were assayed with the polymerase chain reaction (PCR). Results. The 6 affected males had visual acuities ranging from 20/40 to 20/200. All had nystagmus, iris transillumination, and foveal hypoplasia. The eldest affected male was asymptomatic with 20/40 vision. All 7 female carriers had normal visual function but were found to have iris transillumination defects and variable mosaic pigmentary patterns of the retinal pigment epithelium (RPE). Linkage analysis was consistent with a disease-causing mutation at the OA1 locus. PCR analysis revealed a deletion which includes at least the portion of the OA1 gene between exons 2 and 8. Conclusions. Males affected with OA1 can have a visual disability that ranges from almost none to legal blindness. In this family, the visual acuity seemed related more to the degree of nystagmus than to the degree of RPE pigmentation. Mutation screening of the OA1 gene can be used to confirm the diagnosis in isolated males of some families and genetic linkage analysis can be used to accurately identify carriers even when the specific mutation can't be identified.",
author = "Lam, {Byron L} and J. Fingert and Shutt, {B. C.} and Singleton, {E. M.} and Merin, {L. M.} and Sheffield, {V. C.} and Stone, {E. M.}",
year = "1996",
month = "2",
day = "15",
language = "English",
volume = "37",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology Inc.",
number = "3",

}

TY - JOUR

T1 - Clinical and molecular characterization of a family affected with X-linked ocular albinism (OA1)

AU - Lam, Byron L

AU - Fingert, J.

AU - Shutt, B. C.

AU - Singleton, E. M.

AU - Merin, L. M.

AU - Sheffield, V. C.

AU - Stone, E. M.

PY - 1996/2/15

Y1 - 1996/2/15

N2 - Purpose. To characterize the clinical phenotype and identify the disease-causing mutation in a family with X-linked ocular albinism (OA1). Methods. 32 members of a family affected with OA1 were examined, and linkage analysis was performed with markers from the OA1 locus. Exons 2 and 8 of the OA1 gene were assayed with the polymerase chain reaction (PCR). Results. The 6 affected males had visual acuities ranging from 20/40 to 20/200. All had nystagmus, iris transillumination, and foveal hypoplasia. The eldest affected male was asymptomatic with 20/40 vision. All 7 female carriers had normal visual function but were found to have iris transillumination defects and variable mosaic pigmentary patterns of the retinal pigment epithelium (RPE). Linkage analysis was consistent with a disease-causing mutation at the OA1 locus. PCR analysis revealed a deletion which includes at least the portion of the OA1 gene between exons 2 and 8. Conclusions. Males affected with OA1 can have a visual disability that ranges from almost none to legal blindness. In this family, the visual acuity seemed related more to the degree of nystagmus than to the degree of RPE pigmentation. Mutation screening of the OA1 gene can be used to confirm the diagnosis in isolated males of some families and genetic linkage analysis can be used to accurately identify carriers even when the specific mutation can't be identified.

AB - Purpose. To characterize the clinical phenotype and identify the disease-causing mutation in a family with X-linked ocular albinism (OA1). Methods. 32 members of a family affected with OA1 were examined, and linkage analysis was performed with markers from the OA1 locus. Exons 2 and 8 of the OA1 gene were assayed with the polymerase chain reaction (PCR). Results. The 6 affected males had visual acuities ranging from 20/40 to 20/200. All had nystagmus, iris transillumination, and foveal hypoplasia. The eldest affected male was asymptomatic with 20/40 vision. All 7 female carriers had normal visual function but were found to have iris transillumination defects and variable mosaic pigmentary patterns of the retinal pigment epithelium (RPE). Linkage analysis was consistent with a disease-causing mutation at the OA1 locus. PCR analysis revealed a deletion which includes at least the portion of the OA1 gene between exons 2 and 8. Conclusions. Males affected with OA1 can have a visual disability that ranges from almost none to legal blindness. In this family, the visual acuity seemed related more to the degree of nystagmus than to the degree of RPE pigmentation. Mutation screening of the OA1 gene can be used to confirm the diagnosis in isolated males of some families and genetic linkage analysis can be used to accurately identify carriers even when the specific mutation can't be identified.

UR - http://www.scopus.com/inward/record.url?scp=33750167002&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750167002&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33750167002

VL - 37

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

SN - 0146-0404

IS - 3

ER -